On 21 April 2021 a virtual EQIPD workshop entitled “Rigor, reproducibility and data management in nonclinical research” was organized in Finland by the Neuroscience Center (NC), Institute for Molecular Medicine Finland (FIMM), the Helsinki Institute of Life Science (HiLIFE), the University of Helsinki, the European Infrastructure for translational Medicine (EATRIS), PAASP and EQIPD.
This event was intended for researchers and students in the field of life sciences with the aim to give participants both theoretical knowledge and practical insights on factors that contribute to poor research reproducibility and replicability, and how to improve the trustworthiness and quality of research.
Malcolm Macleod, from the University of Edinburgh, stressed the urgency of action in his presentation “Why changes in research practice are needed NOW and why we cannot wait any longer”. 
Thomas Steckler, from Janssen Pharmaceutica NV, in his session entitled “The need to ‘recognize research conducted with sufficient rigor’” explained the significance of randomization, allocation concealment and blinding.
Sami Virtanen from Orion Pharma used examples to demonstrated how raw data can be managed and traced in his presentation “Rigor in data management”. 
“Rigor in collaborative research” was presented by Valentina Vengeliene from PAASP discussing the benefits of scientific collaborations and the EQIPD guidance on industry-academia and academia-academia collaborations.
Finally, Vootele Voikar and Andreas Scherer from HiLIFE ended the workshop with the closing discussion “Do we need a reproducibility network in Finland?” where the majority of participants voted in favor of the establishment of such network.